vimarsana.com

The UK startup Broken String Biosciences has raised a $15 million Series A round to fund the development of a DNA sequencing platform that maps off-target DNA breaks resulting from genome editing technology.

Related Keywords

Amber Bio ,Arnaud Autret , ,Illumina Ventures ,String Bioscience ,Broken String Bioscience ,Raf Roelands ,Markets Amp Regulations ,Emerging Markets ,Cell Amp Gene Therapies ,Seriesa Funding ,Pharmaceutical Industry ,Na ,Na Sequencing ,Genome Editing ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.